METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma

The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation

(2020) Rui-Chao Chai et al.   Acta Neuropathologica Communications

RNA modifications in brain tumorigenesis

(2020) Albert Z. Huang et al.   Acta Neuropathologica Communications

Mechanism of RNA modification N6-methyladenosine in human cancer

(2020) Zijian Zhou et al.   Molecular Cancer

m6A modification in RNA: biogenesis, functions and roles in gliomas

(2020) Yuhao Zhang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas

(2020) Yu-Zhou Chang et al.   Frontiers in Cell and Developmental Biology

Clinical practice guidelines for the management of adult diffuse gliomas

(2020) Tao Jiang et al.   CANCER LETTERS

IL-17 induces the proliferation and migration of glioma cells through the activation of PI3K/Akt1/NF-κB-p65

(2019) Bin Wang et al.   CANCER LETTERS

Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma

(2019) David J. Voce et al.   CANCER RESEARCH

Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma

(2019) Rui-Chao Chai et al.   CARCINOGENESIS

Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma

(2019) Kai Huang et al.   Advanced Science

N6-methyladenosine Modulates Nonsense-mediated mRNA Decay in Human Glioblastoma

(2019) Fuxi Li et al.   CANCER RESEARCH

m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis

(2019) Dan Jin et al.   Journal of Hematology & Oncology

R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m 6 A/MYC/CEBPA Signaling

(2018) Rui Su et al.   CELL

Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism

(2018) Ying Yang et al.   CELL RESEARCH

Multiple functions of m6A RNA methylation in cancer

(2018) Yutian Pan et al.   Journal of Hematology & Oncology

m6A RNA Methylation Controls Neural Development and Is Involved in Human Diseases

(2018) Kunzhao Du et al.   MOLECULAR NEUROBIOLOGY

Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway

(2018) Qixue Wang et al.   Theranostics

Integrated molecular characterization of IDH -mutant glioblastomas

(2018) A. Korshunov et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Cross-talk among writers, readers, and erasers of m6A regulates cancer growth and progression

(2018) Subbarayalu Panneerdoss et al.   Science Advances

PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma

(2018) Zuoxin Zhang et al.   CANCER LETTERS

Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance

(2017) A Visvanathan et al.   ONCOGENE

m 6 A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells

(2017) Qi Cui et al.   Cell Reports

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

CGCG clinical practice guidelines for the management of adult diffuse gliomas

(2016) Tao Jiang et al.   CANCER LETTERS

N6-methyladenosine–encoded epitranscriptomics

(2016) Nian Liu et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling

(2016) Y Han et al.   Cell Death & Disease

N6-methyladenosine–encoded epitranscriptomics

(2016) Nian Liu et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1

(2015) I Vassallo et al.   ONCOGENE

Fate by RNA methylation: m6A steers stem cell pluripotency

(2015) Boxuan Zhao et al.   GENOME BIOLOGY

Gene expression regulation mediated through reversible m6A RNA methylation

(2014) Ye Fu et al.   NATURE REVIEWS GENETICS

AQP5 is differentially regulated in astrocytes during metabolic and traumatic injuries

(2013) Rui Chao Chai et al.   GLIA

N6-methyladenosine-dependent regulation of messenger RNA stability

(2013) Xiao Wang et al.   NATURE

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

(2012) Sevin Turcan et al.   NATURE

Grand Challenge Commentary: RNA epigenetics?

(2010) Chuan He   Nature Chemical Biology